(Senior) Program Manager - Toxicology
Boost your chances before you apply.
WuXi AppTec
US
Summary
Manage Toxicology BU clients' IND programs and oversee drug development progress through technical support and program execution plans. Coordinate between U.S., Europe, and China teams to ensure smooth nonclinical program execution and regulatory compliance.
Job Description
Overview
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with worldwide operations. As an innovation-driven and customer-focused platform, WuXi AppTec provides a broad and integrated portfolio of services to help global customers and partners shorten the discovery and development timeline and reduce the cost of drug and medical device R&D through efficient and cost-effective solutions.
Within our Testing Division, we provide world-class, globally integrated testing solutions to support drug development. We are committed to helping scientists transform innovative ideas into leading healthcare products, accelerating the journey from the laboratory to the clinic, and ultimately improving human health.
We are currently seeking a Program Manager/Sr. Program Manager (depending on experience) to join the Toxicology Strategic Programs team as a U.S.-based remote employee.
This role requires close collaboration with both the U.S. and Europe BD teams, as well as the TOX Commercial Operations Center (TOX COC) in China. The primary working language is English, but due to the need for deep engagement and communication, fluency in Mandarin is highly desired. Preferred location is the U.S. East Coast, particularly the Boston area.
Responsibilities
The Program Manager will primarily support and manage Toxicology BU clients’ IND (Investigational New Drug) programs and oversee drug development progress. He/She will work closely with the LTD International Sales teams, Commercial Market team, TOX COC, TOX SD teams, scientists, and staff at WuXi’s Suzhou, Nantong sites.
- Work independently or under supervision in a highly motivated program management team and dynamic environment.
- Provide technical support during the business development phase, including but not limited to: understanding IND submission requirements of the U.S., China, and EMA; evaluating clients’ development programs; and preparing program proposals and preliminary study designs based on compound characteristics, clinical indications, intended clinical trial plans, existing data, and target submission regions.
- Lead and manage the nonclinical TOX portion of IND-enabling programs: develop program execution plans (Gantt charts), monitor program progress across toxicology, preclinical bioanalysis, and regulatory submission activities; host regular project meetings to review status, study results, issues, and resolutions; and coordinate with other divisions for extended IND programs when needed.
- Provide continuous scientific and technical support during program execution, proactively identify potential issues, and propose constructive solutions.
- Maintain timely communication with clients and key internal contributors across functions/business units via email, teleconferences, Zoom meetings, and/or site visits to ensure smooth program execution.
- Track relevant scientific advances by reviewing literature and sharing updates with the team and business units.
Qualifications
Education & Experience:
- PhD, or MS degree in Toxicology, Pharmacology, DMPK, or related fields.
- 2 - 3 years of post-PhD experience, or 5+ years of experience after a Master’s degree.
- Experience with in vitro or in vivo studies in drug discovery and development required; background in Toxicology and/or DMPK strongly preferred.
- Program management experience in leading nonclinical programs preferred.
- Excellent English verbal and written communication skills; fluency in Mandarin preferred.
- Strong interpersonal and teamwork skills.
- Highly independent with strong accountability.
- Ability to conduct research and perform literature reviews.
Knowledge / Skills / Abilities:
- Strong oral and written communication skills.
- Proficiency in MS Word, Excel, Outlook, PowerPoint, and other relevant software.
- Strong organizational skills, detail-oriented, and adaptable to changes.
- Ability to manage multiple programs under tight deadlines.
- Strong prioritization and flexibility in managing changing directions.
- Team-oriented mindset with flexibility to work across time zones.
- Familiarity with and adherence to regulatory guidelines consistent with company requirements.
The expected annual base salary for this position is $110,000 to $130,000.
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai